GROUNDED IN EVIDENCE. OPEN TO WHAT IS POSSIBLE.Areas of Ongoing Research
At Anew TMS, Dr. Sarah Stone follows this evolving body of research closely. For select patients, she may consider an investigational or off-label TMS approach when the available evidence, the patient’s medical history, and the potential benefits and risks support a thoughtful clinical discussion.
TMS is being studied for conditions beyond its established indications. Below are several areas of active research and what the current evidence suggests. These are evolving fields, and findings should be understood as promising areas of investigation rather than established standards of care
Post-Traumatic Stress
TMS has also been investigated as a potential treatment for post-traumatic stress disorder (PTSD), particularly by targeting brain circuits involved in emotional regulation, fear processing, and traumatic memory.
What the research suggests
Some studies and meta-analyses have reported meaningful reductions in PTSD symptoms following TMS. Other reviews have concluded that the existing evidence is not yet strong enough to establish a clear benefit because studies have generally been small and treatment approaches have varied considerably.
For now, TMS for PTSD remains an evolving area of research.
These applications are investigational. TMS is not FDA-cleared for the conditions described below. The effectiveness of these approaches has not been established, individual results cannot be predicted, and treatment for these indications is typically self-pay rather than covered by insurance.